SCHEMBL22730149

SCHEMBL22730149

CC[Si](Br)(C(C)(C)c1ccccc1)C(C)(C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.40
KCNN4 O15554 3/20 0.39
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 2/20 0.36
HIF1A Q16665 1/20 0.36
ALOX15 P16050 1/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
CYP3A4 P08684 1/20 0.34
KMT2A Q03164 2/20 0.33
NR3C2 P08235 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
NPY2R P49146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22730202 0.92 TAAR1 (0.38) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730241 0.88 TAAR1 (0.35) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730179 0.88 TAAR1 (0.35) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730230 0.85 CYP2C19 (0.34) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730162 0.84 TAAR1 (0.40) TAAR1MAPK1TSHRCYP2C19HIF1A
SCHEMBL8741663 0.77 MAPK1 (0.44) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730200 0.75 MAPK1 (0.42) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730251 0.74 TAAR1 (0.40) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730219 0.74 TAAR1 (0.40) TAAR1KCNN4MAPK1ALDH1A1TSHR
SCHEMBL22730246 0.74 TAAR1 (0.36) TAAR1KCNN4MAPK1ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-07-20 US disclosed
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-10 US disclosed
EP-3747889-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF Shin-Etsu Chemical Co., Ltd. (JP) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066427-B2 Organosilane compounds having bulky substituent and preparation thereof C1S, C1R, C9 TAAR1 1233/4885KCNN4 3367/4885MAPK1 2103/4885
US-20200385411-A1 ORGANOSILANE COMPOUNDS HAVING BULKY SUBSTITUENT AND PREPARATION THEREOF C1S, C1R, C9 TAAR1 1233/4885KCNN4 3367/4885MAPK1 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.